Search

Your search keyword '"Cho AK"' showing total 193 results

Search Constraints

Start Over You searched for: Author "Cho AK" Remove constraint Author: "Cho AK"
193 results on '"Cho AK"'

Search Results

1. Ambient vapor samples activate the Nrf2-ARE pathway in human bronchial epithelial BEAS-2B cells

3. The Pharmacologic Effects of ST-155 (Catapres) and Related Imidazolines in the Rat

4. Plasma and saliva levels of chlorpromazine and subjective response

5. Combined adjuvant effects of ambient vapor-phase organic components and particulate matter potently promote allergic sensitization and Th2-skewing cytokine and chemokine milieux in mice: The importance of mechanistic multi-pollutant research.

6. CYP2D6 genotype may moderate measures of brain structure in methamphetamine users.

7. Chemical speciation, including polycyclic aromatic hydrocarbons (PAHs), and toxicity of particles emitted from meat cooking operations.

8. A Chemical Perspective of Pharmacology and Toxicology.

9. Impact of biodiesel on regulated and unregulated emissions, and redox and proinflammatory properties of PM emitted from heavy-duty vehicles.

10. Carbohydrate Composition Associated with the 2-Year Incidence of Metabolic Syndrome in Korean Adults.

11. Trends in Tramadol: Pharmacology, Metabolism, and Misuse.

12. Chemical reactivities of ambient air samples in three Southern California communities.

13. Clinical and pharmacological aspects of bath salt use: a review of the literature and case reports.

14. Redox cycling of 1,2-naphthoquinone by thioredoxin1 through Cys32 and Cys35 causes inhibition of its catalytic activity and activation of ASK1/p38 signaling.

15. The chemical biology of naphthoquinones and its environmental implications.

16. Physiological response of normal and RD mouse retinal ganglion cells to electrical stimulation.

17. Glyceraldehyde-3-phosphate dehydrogenase as a quinone reductase in the suppression of 1,2-naphthoquinone protein adduct formation.

18. GSH-mediated S-transarylation of a quinone glyceraldehyde-3-phosphate dehydrogenase conjugate.

19. Retinal prostheses: current clinical results and future needs.

20. Initial response and cellular protection through the Keap1/Nrf2 system during the exposure of primary mouse hepatocytes to 1,2-naphthoquinone.

21. Physiological response of mouse retinal ganglion cells to electrical stimulation: effect of soma size.

22. Redox and electrophilic properties of vapor- and particle-phase components of ambient aerosols.

23. Determination of metal-based hydroxyl radical generating capacity of ambient and diesel exhaust particles.

24. Oxidative potential of semi-volatile and non volatile particulate matter (PM) from heavy-duty vehicles retrofitted with emission control technologies.

25. Electrophilic and redox properties of diesel exhaust particles.

26. Long-term methamphetamine administration in the vervet monkey models aspects of a human exposure: brain neurotoxicity and behavioral profiles.

27. Redox cycling of 9,10-phenanthraquinone to cause oxidative stress is terminated through its monoglucuronide conjugation in human pulmonary epithelial A549 cells.

28. Chemical knockdown of protein-tyrosine phosphatase 1B by 1,2-naphthoquinone through covalent modification causes persistent transactivation of epidermal growth factor receptor.

29. An approach to evaluate two-electron reduction of 9,10-phenanthraquinone and redox activity of the hydroquinone associated with oxidative stress.

30. Effects of naphthoquinone on airway responsiveness in the presence or absence of antigen in mice.

31. Relationship between redox activity and chemical speciation of size-fractionated particulate matter.

32. Methamphetamine blood concentrations in human abusers: application to pharmacokinetic modeling.

33. Escalating dose pretreatment induces pharmacodynamic and not pharmacokinetic tolerance to a subsequent high-dose methamphetamine binge.

34. 1,2-Naphthoquinone activates vanilloid receptor 1 through increased protein tyrosine phosphorylation, leading to contraction of guinea pig trachea.

35. Redox activity of airborne particulate matter at different sites in the Los Angeles Basin.

36. Inhalation of concentrated ambient particulate matter near a heavily trafficked road stimulates antigen-induced airway responses in mice.

37. Prolonged exposure of rats to intravenous methamphetamine: behavioral and neurochemical characterization.

38. The interactions of 9,10-phenanthrenequinone with glyceraldehyde-3-phosphate dehydrogenase (GAPDH), a potential site for toxic actions.

39. Effects of a single intratracheal administration of phenanthraquinone on murine lung.

40. Inherent redox properties of diesel exhaust particles: catalysis of the generation of reactive oxygen species by biological reductants.

41. An examination of quinone toxicity using the yeast Saccharomyces cerevisiae model system.

42. Escalating dose methamphetamine pretreatment alters the behavioral and neurochemical profiles associated with exposure to a high-dose methamphetamine binge.

43. Patterns of methamphetamine abuse and their consequences.

44. Structural and spectroscopic analysis of the F393H mutant of flavocytochrome P450 BM3.

45. Inactivation of rat cytochrome P450 2D enzyme by a further metabolite of 4-hydroxypropranolol, the major and active metabolite of propranolol.

46. Relevance of pharmacokinetic parameters in animal models of methamphetamine abuse.

47. Metabolism of drugs of abuse by cytochromes P450.

48. Caudate-putamen dopamine and stereotypy response profiles after intravenous and subcutaneous amphetamine.

49. l-methamphetamine pharmacokinetics and pharmacodynamics for assessment of in vivo deprenyl-derived l-methamphetamine.

50. Oxidation of methamphetamine and methylenedioxymethamphetamine by CYP2D6.

Catalog

Books, media, physical & digital resources